Author: Contec Cleanroom
Tags:Pharmaceutical Manufacturing, Annex 1, Cleanovators, Webinar

Quality Risk Management in Aseptic Processing

This Contec Cleanroom webinar session sets the stage for understanding how regulatory expectations are evolving toward a more holistic and risk-based approach in sterile medicinal product manufacturing.
00:0300:05

Webinar Description

 

This webinar introduces quality risk management (QRM) as a foundational tool for enabling an effective contamination control strategy (CCS). The session sets the stage for understanding how regulatory expectations are evolving toward a more holistic and risk-based approach. 

Key Takeaways

  • Annex 1 requires a holistic, lifecycle-based contamination control strategy for sterile manufacturing.
  • Quality Risk Management is the foundational tool that enables an effective CCS.
  • Risk assessments should follow a structured ICH Q9 process, beginning with a clearly defined risk question.
  • Manufacturers must evaluate not only whether controls exist, but whether they are effective and appropriately designed.
  • Integrating microbiological, technical, and process knowledge strengthens contamination prevention and regulatory alignment.

Webinar Resources

Webinar Section Summaries

Scope and Impact of Annex 1 on Sterile Manufacturing

 

Annex 1 applies broadly to sterile medicinal products, including small molecules, biologics, cell therapies, and combination products. It governs the entire product lifecycle—from facility design through final container closure. The revision increases expectations for manufacturers to evaluate aseptic operations comprehensively and align their processes with contamination control principles across all stages of production.

 

Understanding the Contamination Control Strategy (CCS)

 

Annex 1 requires manufacturers to establish a documented, holistic contamination control strategy. This includes identifying critical control points, implementing appropriate monitoring measures, and ensuring preventive and detective controls are integrated across operations.

 

The CCS encompasses:

 

  • Facility and equipment design
  • Raw material controls
  • Cleaning and sanitization programs
  • Environmental monitoring
  • Utility systems
  • Process design and aseptic techniques

 

The strategy must be both preventive and responsive, ensuring risks are understood and mitigated proactively.

 

The Role of Quality Risk Management (QRM)

 

Quality Risk Management is positioned as the mechanism that enables a robust CCS. The transcript emphasizes that QRM should not be viewed as a regulatory checkbox exercise, but rather as a structured, science-based decision-making framework.

 

The speaker highlights that regulatory guidance can present QRM expectations differently, which can cause confusion. Therefore, understanding core QRM terminology and principles is essential for consistent application.

 

Conducting Risk Assessments Under ICH Q9

 

When Annex 1 calls for a “risk assessment,” it refers to a systematic process aligned with ICH Q9.

 

A risk assessment typically includes:

 

  • Defining the risk question (establishing scope and boundaries)
  • Hazard identification
  • Risk analysis (likelihood and consequence)
  • Risk evaluation (prioritization of risks)
  • Risk control (mitigation actions)
  • Risk communication and review

 

A clearly defined risk question prevents scope creep and keeps teams focused. Proper hazard identification and structured analysis allow organizations to prioritize meaningful risks rather than attempting to address everything equally.

 

Evaluating and Improving Control Effectiveness

 

A key theme of the webinar is evaluating whether existing controls are truly effective. Organizations often layer additional controls in response to recurring failures without reassessing the root cause or overall control strategy.

 

Annex 1 encourages manufacturers to:

 

  • Step back and evaluate control layers
  • Determine whether controls are working as intended
  • Streamline or redesign mitigation strategies where necessary

 

The focus shifts from simply adding controls to ensuring they are appropriate, effective, and sustainable.

 

Integrating Technical and Process Knowledge

 

An effective contamination control strategy requires strong integration of technical knowledge (e.g., microbiology, facility engineering) and process knowledge (e.g., aseptic workflows, operational practices).

 

The speaker emphasizes that QRM must incorporate both dimensions. Risk decisions should be grounded in scientific understanding of microorganisms, contamination pathways, and operational realities to ensure meaningful mitigation.

 

ANSI/PDA Risk Management Standard for Aseptic Processing

 

The webinar references ongoing work led by PDA to develop an ANSI standard focused on quality risk management in aseptic processing. This standard aims to provide structured principles that help organizations consistently apply QRM in alignment with Annex 1 expectations.

 

The goal is to make risk management practical, standardized, and embedded within aseptic operations rather than treated as a separate compliance activity.

 

Using QRM as a Contamination Control Enabler

 

The central message of the session is that QRM should function as an enabler of contamination control—not just documentation for regulators.

 

When implemented effectively, QRM:

 

  • Guides identification of critical control points
  • Supports rational monitoring strategies
  • Helps prioritize resources
  • Strengthens contamination prevention
  • Promotes continuous improvement

 

A mature QRM process allows organizations to take a holistic, lifecycle-based view of sterile manufacturing risks.

More from Studio 289

Behind the Scenes